LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 Radicicol
3.33
uM
LJP6
1
K08
72
hr
1097 977 3769 0.2592 -0.0450
BT-20 Radicicol
3.33
uM
LJP6
2
K08
72
hr
1097 978 3769 0.2595 -0.0446
BT-20 Radicicol
3.33
uM
LJP6
3
K08
72
hr
1097 1068 3769 0.2833 -0.0109
BT-20 Seliciclib
3.33
uM
LJP5
1
J02
72
hr
1097 2731 3769 0.7245 0.6114
BT-20 Seliciclib
3.33
uM
LJP5
2
J02
72
hr
1097 3060 3769 0.8118 0.7345
BT-20 Seliciclib
3.33
uM
LJP5
3
J02
72
hr
1097 2711 3769 0.7192 0.6039
BT-20 Ruxolitinib
3.33
uM
LJP5
1
O14
72
hr
1097 3916 3769 1.0389 1.0548
BT-20 Ruxolitinib
3.33
uM
LJP5
2
O14
72
hr
1097 3908 3769 1.0367 1.0518
BT-20 Ruxolitinib
3.33
uM
LJP5
3
O14
72
hr
1097 3747 3769 0.9940 0.9916
BT-20 XL147
3.33
uM
LJP5
1
G08
72
hr
1097 3139 3769 0.8327 0.7641
BT-20 XL147
3.33
uM
LJP5
2
G08
72
hr
1097 3495 3769 0.9272 0.8973
BT-20 XL147
3.33
uM
LJP5
3
G08
72
hr
1097 3321 3769 0.8810 0.8322
BT-20 Saracatinib
3.33
uM
LJP6
1
D08
72
hr
1097 2154 3769 0.5714 0.3955
BT-20 Saracatinib
3.33
uM
LJP6
2
D08
72
hr
1097 2619 3769 0.6948 0.5695
BT-20 Saracatinib
3.33
uM
LJP6
3
D08
72
hr
1097 2242 3769 0.5948 0.4284
BT-20 Selumetinib
3.33
uM
LJP6
1
M08
72
hr
1097 3243 3769 0.8603 0.8030
BT-20 Selumetinib
3.33
uM
LJP6
2
M08
72
hr
1097 3301 3769 0.8757 0.8247
BT-20 Selumetinib
3.33
uM
LJP6
3
M08
72
hr
1097 3538 3769 0.9386 0.9134
BT-20 Sirolimus
3.33
uM
LJP6
1
L14
72
hr
1097 2361 3769 0.6263 0.4729
BT-20 Sirolimus
3.33
uM
LJP6
2
L14
72
hr
1097 2284 3769 0.6059 0.4441
BT-20 Sirolimus
3.33
uM
LJP6
3
L14
72
hr
1097 2285 3769 0.6062 0.4445
BT-20 Sorafenib
3.33
uM
LJP6
1
B08
72
hr
1097 3211 3769 0.8518 0.7910
BT-20 Sorafenib
3.33
uM
LJP6
2
B08
72
hr
1097 3037 3769 0.8057 0.7259
BT-20 Sorafenib
3.33
uM
LJP6
3
B08
72
hr
1097 3084 3769 0.8181 0.7435
BT-20 SU11274
3.33
uM
LJP5
1
J08
72
hr
1097 3414 3769 0.9057 0.8670